Patent · US Active

Coagulation factor VII compositions and methods of making and using same

US8716448B2 · kind B2 · utility

26Cited by

16References

42Claims

0Family size

Assignee

Amunix Operating Inc. · US

Inventors

Volker Schellenberger · Palo Alto, US
Joshua Silverman · Los Altos Hills, US
Willem P. Stemmer · Menlo Park, US
Chia-Wei Wang · Santa Clara, US
Benjamin Spink · San Carlos, US
Nathan Geething · Santa Clara, US
Wayne To · San Mateo, US

Key dates

Filing date	Aug 2, 2010
Grant date	May 6, 2014
Priority date	—
Expiry date	Dec 17, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising factor VII coagulation factors linked to extended recombinant polypeptide (XTEN), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of making and using such compositions in treatment of coagulation factor-related diseases, disorders, and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.